middle.news
EVE Health Advances ED and Dysmenorrhea Treatments with Key Stability Testing Milestone
11:46pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
EVE Health Advances ED and Dysmenorrhea Treatments with Key Stability Testing Milestone
11:46pm on Monday 2nd of June, 2025 AEST
Key Points
Stability testing commenced for new oral ED and dysmenorrhea products
Regulatory submissions to Australia's Therapeutic Goods Administration planned for mid-2025
Approvals expected before the end of 2025
EVE completed TGA registration as sponsor and manufacturer
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Eve Health (ASX:EVE)
OPEN ARTICLE